Targovax's Grant - III Round

Targovax raised a round of funding on June 06, 2013. Investors include Norges Forskningsråd.

Targovax is an Oslo-area based global biotechnology company, dedicated to the design and development of immunotherapy vaccines for patients with RAS-mutated cancers.…

Articles about Targovax's Grant - III Round: